The release of protein-coated exosomes called PD-L1, part of immune checkpoint protein family actively involved in immune surveillance, in melanoma skin cancer models and in blood samples of the people treated for breast and lung cancer [162] suggest a novel method to increase the efficacy of exosomes dependent tumor vaccines. This evidence concerns the gene CD274 and neoplasm.